A detailed history of Jefferies Financial Group Inc. transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 17,000 shares of MRVI stock, worth $136,850. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,000
Previous 44,500 61.8%
Holding current value
$136,850
Previous $385,000 68.57%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$6.87 - $11.34 $188,925 - $311,850
-27,500 Reduced 61.8%
17,000 $121,000
Q1 2024

May 13, 2024

BUY
$5.11 - $8.76 $140,525 - $240,900
27,500 Added 161.76%
44,500 $385,000
Q4 2023

Feb 13, 2024

BUY
$4.7 - $9.87 $8,239 - $17,302
1,753 Added 11.5%
17,000 $111,000
Q3 2023

Nov 14, 2023

BUY
$9.14 - $12.85 $139,357 - $195,923
15,247 New
15,247 $152,000
Q4 2022

Feb 14, 2023

BUY
$12.5 - $24.78 $189,575 - $375,813
15,166 New
15,166 $217,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $1.06B
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.